Find Clinical Trial

Home » Find Clinical Trials » Effects of terutroban versus aspirin on composition of atherosclerotic plaque in patients undergoing a carotid endarterectomy. A multicentre, randomised, double blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally. –

Effects of terutroban versus aspirin on composition of atherosclerotic plaque in patients undergoing a carotid endarterectomy. A multicentre, randomised, double blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally. –

← Back

Study Phase	Phase 2

Therapeutic Area	Cardiovascular Diseases

Indication	Stroke

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	TERUTROBAN, S018886

Active Substance Code	S018886

Protocol Code	CL2-18886-026

EudraCT Code	2007-000176-17

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.